Pilot Study to Evaluate Knee Osteoarthritis Outcome Measures in Arthritic Patients Prescribed Forteo or Prolia for Osteoporosis
Status: Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 30 Oct 2019
Price : $35 *
At a glance
- Drugs Denosumab (Primary) ; Teriparatide (Primary)
- Indications Osteoarthritis; Osteoporosis
- Focus Biomarker; Proof of concept; Therapeutic Use
- 22 Oct 2019 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 04 Apr 2019 Planned End Date changed from 31 Dec 2023 to 31 Dec 2024.
- 04 Apr 2019 Planned primary completion date changed from 31 Dec 2022 to 31 Dec 2023.